Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 6/20 | 0.80 |
| ▸ | CYP19A1 | P11511 | 10/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL230368 | 0.98 | HSP90AB1 (0.82) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL21293881 | 0.97 | HSP90AB1 (0.80) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| Sulfuric Acid SCHEMBL28657977 | 0.91 | HSP90AB1 (0.68) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL18028297 | 0.90 | HSP90AB1 (0.70) | HSP90AB1CYP19A1NPC1RAB9A | |
| SCHEMBL10044915 | 0.89 | HSP90AB1 (0.69) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL15425743 | 0.87 | CYP19A1 (0.67) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL17104470 | 0.86 | CYP19A1 (0.67) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL805203 | 0.86 | HSP90AB1 (0.65) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL29055929 | 0.85 | CYP19A1 (0.65) | HSP90AB1CYP19A1NPC1RAB9AHRH4 | |
| SCHEMBL16463657 | 0.84 | HSP90AB1 (0.63) | HSP90AB1CYP19A1NPC1RAB9AHRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118284596-A | Substituted diazenyl anilines as fluorescence quenchers and their use | 科学与工业研究会(按照印度社会团体注册法案(1860年第21号法案)设立的注册机构) | 2024-07-02 | — | — | CN | disclosed |